InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Garcia Peter S, 首席财务官. Insider active across 3 companies, notably ALX Oncology Holdings INC. Cumulatively, 18 reports have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €232k. History available since 17 August 2021. The latest transaction was filed on 9 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Garcia Peter S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
12,500 股Common StockSEC:0000950170-25-114650:0
5,500 股@ US$1.22100.0% 占其流量Common StockSEC:0000950170-25-114308:0
761 股@ US$2.580.2% 占其流量Common StockSEC:0001415889-24-021476:0
1,789 股@ US$6.031.2% 占其流量Common StockSEC:0001415889-24-018919:0
12,000 股@ US$8.528211.4% 占其流量Common StockSEC:0001415889-24-017899:0
标准退出：2024年9月11日 (T+90)
12,000 股@ US$8.528211.4% 占其流量Common StockSEC:0001415889-24-017054:0
标准退出：2024年9月11日 (T+90)
25,000 股0Common StockSEC:0001415889-24-004231:0
1,893 股@ US$15.043.1% 占其流量Common StockSEC:0001209191-24-000366:0
32,000 股0Common StockSEC:0001209191-23-043519:0
887 股@ US$7.340.7% 占其流量Common StockSEC:0001209191-23-041175:0
893 股@ US$11.07011.1% 占其流量Common StockSEC:0001209191-23-000475:0
29,000 股0Common StockSEC:0001209191-22-045056:0
6,637 股@ US$4.085.3% 占其流量Common StockSEC:0001209191-22-007887:0
7,229 股@ US$4.085.7% 占其流量Common StockSEC:0001209191-21-060910:0
1,426 股@ US$4.081.1% 占其流量Common StockSEC:0001209191-21-056787:0
60,000 股@ US$4.0846.8% 占其流量Common StockSEC:0001209191-21-053218:0
10,000 股@ US$4.087.8% 占其流量Common StockSEC:0001209191-21-052397:0
101,051 股Common stockSEC:0000882104-16-000098:0
18 条申报中的 18 条
About Garcia Peter S
GARCIA PETER S is Chief Financial Officer. He has 18 filings in total, and within the recent sampled filings covered here, buy volume is EUR 190595 and sell volume is EUR 41014, with filings dated from 2016-01-28 to 2025-09-12. He is associated with ALX Oncology Holdings INC, DURECT CORP and PDL BIOPHARMA, INC.
